DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

DongKoo Bio & Pharma Revenue

DongKoo Bio & Pharma had revenue of 62.02B KRW in the quarter ending September 30, 2025, a decrease of -6.29%. This brings the company's revenue in the last twelve months to 238.39B, down -6.04% year-over-year. In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B with 15.57% growth.

• Revenue (ttm): 238.39B
• Revenue Growth: -6.04%
• P/S Ratio: 0.59
• Revenue / Employee: 590.07M
• Employees: 404
• Market Cap: 140.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	249.27B	33.59B	15.57%
Dec 31, 2023	215.69B	20.70B	10.62%
Dec 31, 2022	194.99B	39.84B	25.68%
Dec 31, 2021	155.15B	15.93B	11.45%
Dec 31, 2020	139.22B	38.09B	37.67%